FDA Adverse Event Other Summary report: N

SYNVISC (HYLAN G-F 20) INJECTION

MDR report key: 3181999 · Received June 14, 2013

Report

Report Number
2246315-2013-00357
Event Type
Other
Date Received
June 14, 2013
Report Date
June 7, 2013
Manufacturer
GENZYME BIOSURGERY (RIDGEFIELD)
Product Code
MOZ
PMA / PMN Number
P940015
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CO, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

MANUFACTURER'S COMMENT: THE BENEFIT-RISK RELATIONSHIP OF SYNVISC IS NOT AFFECTED BY THIS REPORT.

Description of Event or Problem · 1

LEFT KNEE EFFUSION [JOINT EFFUSION]. CASE DESCRIPTION: SPONTANEOUS CASE WAS RECEIVED ON (B)(6) 2013 FROM A HEALTH CARE PROFESSIONAL REGARDING A (B)(6) FEMALE PT, INITIALS (B)(6). THE PT'S MEDICAL HISTORY WAS NOT PROVIDED. ON AN UNSPECIFIED DATE, THE PT INITIATED TREATMENT WITH SYNVISC (HYLAN G-F 20) INJECTION (ROUTE AND DOSAGE REGIMEN NOT PROVIDED) IN LEFT KNEE. THE LOT NUMBER FOR SYNVISC WAS NOT PROVIDED. ON AN UNSPECIFIED DATE, TWO DAYS AFTER INITIATION OF TREATMENT WITH SYNVISC, THE PT WAS TAKEN TO THE EMERGENCY ROOM. IT WAS REPORTED THAT THE HOSPITAL RULED OUT DEEP VEIN THROMBOSIS AND THE PT'S SEDIMENTATION RATE WAS NORMAL. ON AN UNSPECIFIED DATE, THE PT RETURNED TO THE CLINIC AND THE PHYSICIAN ASPIRATED 60 ML OF FLUID FROM THE LEFT KNEE OF PT. THE ACTION TAKEN WITH SYNVISC TREATMENT WAS NOT PROVIDED. THE PT RECOVERED FROM THE EVENT. CONCOMITANT MEDICATIONS WERE NOT PROVIDED. THE INTENSITY FOR THE EVENT WAS NOT PROVIDED. THE REPORTING PHYSICIAN DID NOT PROVIDE THE CAUSAL RELATIONSHIP BETWEEN SYNVISC AND THE EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
271510 SYNVISC (HYLAN G-F 20) INJECTION INTRA-ARTICULAR HYALURONIC ACID MOZ GENZYME BIOSURGERY (RIDGEFIELD) UNK UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 61 YR Required Intervention